If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIdox Group Regulatory News (IDOX)

  • There is currently no data for IDOX

Year End Trading Update

22 Nov 2023 07:00

RNS Number : 2040U
IDOX PLC
22 November 2023
 

22 November 2023

Idox plc

('Idox', the 'Group' or the 'Company')

Year End Trading Update

A resilient performance in line with expectations

 

Idox plc (AIM: IDOX), a leading supplier of specialist information management software and Geospatial data solutions to the public and asset intensive sectors, today issues a trading update for its financial year ended 31 October 2023 ('FY23').

 

Group trading performance

 

Building on the significant progress the Group has made over the past few years, we are pleased to report Idox has again delivered a resilient performance in line with expectations for FY23 despite the backdrop of continued geo-political and economic uncertainty. We have continued to make good progress towards a number of our medium-term strategic goals, placing the Group on a firm footing for FY24 and beyond.

 

The Group delivered a record order intake of over £82m in FY23, an increase of c.11% on the prior year, reflecting our high-quality customer base and strong market positions.

 

The Board expects to report (subject to external audit) revenue and profit in line with expectations; revenue is expected to be up c.11% to c.£73m, with recurring revenue up c.8% over the period to c.£44m, delivering a c.9% increase in full year adjusted EBITDA to c.£24.5m and a robust adjusted EBITDA margin of c.34% (FY22: 34%).

 

Net debt at 31 October 2023 was £14.7m, including the initial cash consideration of £14.8m paid for Emapsite.com Limited ('Emapsite') as announced on 21 August 2023 (FY22: net debt of £6.7m). In September 2023 the Group completed the refinancing of its lending facilities to a new £75m revolving credit facility and a £45m accordion, a significant increase on the previous facilities which consisted of a revolving credit facility of £35m and £10m accordion, respectively. The new facilities, which are on improved terms, are for a three-year period with two extension options of one year each. The new facilities are provided by the Group's existing syndicate of banks: HSBC Innovation, NatWest and Santander.

 

The integration of Emapsite is underway and will enhance the Group's data capabilities whilst adding significant scale to our Geospatial offering. The Group continues to evaluate a number of further acquisition opportunities, remaining focussed on ensuring strategic alignment at appropriate valuations.

 

We have started FY24 with good levels of visibility - strong recurring revenue, a solid order book and a healthy order pipeline supported by a strengthened financial platform. As a result, our expectations for FY24 remain unchanged, notwithstanding the current macro-environment.

 

David Meaden, Chief Executive Officer of Idox commented:

 

"We are pleased to deliver another solid performance including double-digit revenue growth despite a challenging geo-political and economic backdrop. Our recurring revenue and order intake are both up on the prior year and this provides a solid foundation as we start the new financial year.

 

We are very pleased with the acquisition of Emapsite which adds significant scale and expertise to our existing Geospatial data capabilities. We are excited by the growth opportunities available in this sector, adding to our existing market leading public software capabilities.

 We were delighted to complete a refinancing in the period. The new and increased facilities, which are on improved terms, support our strategic M&A ambitions supplementing our organic growth strategy. Despite the challenging headwinds, our resilient business model allows us to look forward with confidence."

 

 

Notice of results

 

The Group expects to report its FY23 results in late January 2024. Management intends to host a results webinar on the day. Please contact MHP to register your interest.

 

 

Definitions

 

Adjusted EBITDA is defined as earnings before amortisation, depreciation, restructuring, acquisition costs, impairment, financing costs and share option costs.

 

Net debt is defined as the aggregation of cash, bank borrowings and long-term bond.

 

 

For further information please contact:

 

Idox plc

Chris Stone, Non-Executive Chairman

David Meaden, Chief Executive Officer

Anoop Kang, Chief Financial Officer

 

+44 (0) 870 333 7101

investorrelations@idoxgroup.com

Peel Hunt LLP (NOMAD and Broker)

Paul Gillam

Michael Burke

James Smith

 

+44 (0) 20 7418 8900

MHP

Reg Hoare

Ollie Hoare

Matthew Taylor

 

+ 44 (0) 20 3128 8100

idox@mhpgroup.com

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUARRROSUAUUA
Date   Source Headline
19th Feb 20217:39 amRNSStatement re Possible Offer
19th Feb 20217:00 amRNSStatement re Possible Offer
3rd Feb 20217:00 amRNSAGM Date & Dividend Payment Schedule
2nd Feb 20217:00 amRNSFY20 Results
19th Jan 20214:05 pmRNSExercise of Share Options & Total Voting Rights
19th Jan 20217:00 amRNSNotice of Final Results
2nd Dec 20207:00 amRNSContract Win
2nd Dec 20207:00 amRNSExercise of Share Options and Total Voting Rights
26th Nov 202011:37 amRNSInvestor presentation
17th Nov 20207:00 amRNSYear End Trading Update
27th Oct 20207:00 amRNSExercise of Share Options & Total Voting Rights
22nd Oct 20205:35 pmRNSHolding(s) in Company
21st Oct 20207:00 amRNSAppointment of Head of Professional Services
14th Oct 20205:45 pmRNSReplacement: Exercise of Share Options & TVR
14th Oct 202011:51 amRNSHolding(s) in Company
14th Oct 20207:00 amRNSIdox Rebrand and Recent Progress with Idox Cloud
13th Oct 20207:00 amRNSExercise of Share Options & Total Voting Rights
23rd Sep 20205:30 pmRNSHolding(s) in Company
28th Aug 20207:00 amRNSDirectorate Changes
25th Aug 20207:00 amRNSExercise of Share Options & Total Voting Rights
16th Jul 20207:00 amRNSExercise of Share Options & Total Voting Rights
8th Jul 20201:58 pmRNSHolding(s) in Company
19th Jun 20207:00 amRNSGrant of Options
15th Jun 20207:00 amRNSHalf-year Report
28th May 202011:18 amRNSResult of AGM
19th May 20207:00 amRNSHalf Year Trading Update
1st May 20207:42 amRNSPosting of Annual Report and Notice of AGM
28th Apr 20204:33 pmRNSHolding(s) in Company
20th Apr 20208:01 amRNSProgressive publishes new research
14th Apr 20207:01 amRNSDirectorate Change
14th Apr 20207:00 amRNSFinal Results
30th Mar 20204:36 pmRNSPrice Monitoring Extension
23rd Mar 20207:00 amRNSNotice of Results Update
16th Mar 20207:00 amRNSTrading Update and Notice of Results update
7th Feb 202011:33 amRNSHolding(s) in Company
7th Feb 202011:29 amRNSNotice of Results
23rd Jan 20207:00 amRNSChange of Adviser and Notice of Results
22nd Jan 202012:44 pmRNSAIM Rule 17 Schedule Two (g) Update
17th Jan 202012:12 pmRNSDirectors' Dealings & Holdings in Company
3rd Jan 20207:00 amRNSDirectors' Dealings & Holdings in Company
24th Dec 201912:49 pmRNSDirectors' Dealings & Holdings in Company
19th Dec 20197:00 amRNSNew Banking Facilities
2nd Dec 20192:45 pmRNSDirectors' Dealings & Holdings in Company
27th Nov 20192:54 pmRNSDirectors' Dealings & Holdings in Company
27th Nov 20192:10 pmRNSHolding(s) in Company
27th Nov 20192:08 pmRNSHolding(s) in Company
25th Nov 20197:00 amRNSYear End Trading Update
3rd Oct 20192:09 pmRNSExercise of Share Options & Total Voting Rights
17th Sep 20193:03 pmRNSHolding(s) in Company
30th Aug 201910:02 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.